Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000082228 | SCV000114177 | benign | not specified | 2012-12-19 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000082228 | SCV000247274 | likely benign | not specified | 2015-06-29 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000550854 | SCV000636599 | benign | Kleefstra syndrome 1 | 2024-01-30 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002313824 | SCV000847960 | likely benign | Inborn genetic diseases | 2018-07-24 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001689631 | SCV001907680 | benign | not provided | 2018-10-23 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003952527 | SCV004783005 | benign | EHMT1-related condition | 2019-08-20 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |